Golden Recursion Inc. logoGolden Recursion Inc. logo
Advanced Search


Inato matches the right sites to the right clinical research study, globally.

Inato, founded in 2016 and headquartered in Paris, France, is a company developing an artificial intelligence module that matches biopharmaceutical trials to qualified testing sites around the world. Inato works in conjunction with pharmaceutical companies and Contract Research Organizations to develop a marketplace for clinical research sites around the world.

Inato has a second office located in New York. Their services have been utilized in over 75 countries, accounting for over 3,500 doctors and 2,000 testing sites. Inato's AI system utilizes the following data points:

  • Patient accessibility
  • Location capacity
  • Doctor participation interest
  • In-network sites willing to assist in patient accessibility

COVID-19 Research and Response

Inato's Anticovid Platform gathers, organizes, and analyzes all COVID-19 clinical trial data in one open-access hub. Anticovid presents these insights to hospitals and doctors at no charge to facilitate:

  1. Search and access for the most up-to-date COVID-19 trial information
  2. Analysis and understanding of the emerging COVID-19 clinical trial trends, so that medical professionals can participate in or support in trials.


June 11, 2020
Inato joins SCRS as a global impact partner.
June 11, 2020
Growing From A Feasibility Platform To A Clinical Trials Marketplace
February 14, 2020
Inato raised €13 million in a Series A round of venture capital financing.
November 15, 2017
Inato raises €1.3 million to lower drug prices through better clinical trial recruitment.
Inato founded by Kourash Davarpanah, Philippe Ravaud, William Pambrum, and Jean-David Zeitoun.


Further Resources


Another Venture Attempts to Conquer Research Site Selection with Algorithmic-based Performance Metrics


February 5, 2020

Inato raises $14M to unlock trial site potential

Ben Adams


February 5, 2020

Inato Unveils Central, Searchable Repository for all COVID-19 Clinical Trials

Inato SAS


April 14, 2020

Paris-based Inato raises €1.3 million to lower drug prices through better clinical trial recruitment

Thomas Ohr


November 15, 2017

Serena, Obvious Ventures Invest In This Clinical Trial Marketplace's $14M Series...

Natasha Mascarenhas


February 4, 2020


Golden logo
By using this site, you agree to our Terms & Conditions.